[ Blueprint Genetics raises $15.96M in Series A ]

Blueprint Genetics has raised $15.96 million in Series A funding.

Founded in 2012, Blueprint Genetics  is a healthcare firm that provides clinical sequencing and genetic testing services to patients.

The company plans to use the fresh cash  to accelerate further growth, strengthen sales, expand its geographic presence and establish programs to further increase the efficiency of its sequencing platform and continue the development of its software component and data pool to make interpretation of genetic data more efficient.

Funding  Series A
Founded  2012
Country  Finland
City  Helsinki, Southern Finland
Founder / CEO  Tommi Lehtonen
Deal Size  $15.96M
Investors  Stanford University
 Inventure Oy
 Pontos Group
 MedTech Innovation Partners
 Creathor Venture
Previous Investors  Inventure Oy
 Pontos Group